Tag: Transitional cell carcinoma

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Transitional cell carcinoma

Durvalumab by AstraZeneca for Esophageal Cancer: Likelihood of Approval

Added to Collection on: 2023-10-27 22:10:03

Tags for this article:

Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Oncology
Squamous-cell carcinoma
Durvalumab
Neprilysin
Chemotherapy regimen
Thyroid neoplasm
Bladder cancer
Transitional cell carcinoma
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Two Studies Show Improved Survival With Novel Front-Line Combinations in Advanced ...

Added to Collection on: 2023-11-16 21:42:48

Tags for this article:

Antineoplastic drugs
Breakthrough therapy
Cancer immunotherapy
Orphan drugs
Nivolumab
Pembrolizumab
Bladder cancer
Transitional cell carcinoma
Enfortumab vedotin
Seagen
Checkpoint inhibitor
Chemotherapy
Thomas Powles
Gemcitabine
Michiel van der Heijden
Cisplatin

Click the tags to see associated articles and topics

View Article Details
Atezolizumab by F. Hoffmann-La Roche for Colorectal Cancer: Likelihood of Approval

Added to Collection on: 2023-12-25 18:21:40

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Atezolizumab
Carcinoma
Infectious causes of cancer
Bevacizumab
Non-small-cell lung cancer
Small-cell carcinoma
Targeted therapy
Transitional cell carcinoma
Anaplastic lymphoma kinase
F. Hoffmann-La Roche
HOFFMANN - LA ROCHE

Click the tags to see associated articles and topics

View Article Details
Palbociclib by Pfizer for Mantle Cell Lymphoma: Likelihood of Approval

Added to Collection on: 2023-12-26 17:13:01

Tags for this article:

Aminopyridines
Breast cancer
Lactams
Palbociclib
HER2
Fulvestrant
Metastatic breast cancer
Chemotherapy regimen
Transitional cell carcinoma
CDK inhibitor
Abemaciclib
PD-0332991
Pfizer

Click the tags to see associated articles and topics

View Article Details
Keytruda Improves Disease-Free Survival in Advanced Bladder Cancer - Cure Today

Added to Collection on: 2024-01-28 20:05:54

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Immune system
Clusters of differentiation
Pembrolizumab
Nivolumab
Adjuvant therapy
Checkpoint inhibitor
Transitional cell carcinoma
Bladder cancer
Programmed cell death protein 1
PD

Click the tags to see associated articles and topics

View Article Details
Pfizer and Astellas seek updated EMA approval for Padcev with Keytruda

Added to Collection on: 2024-01-29 16:46:26

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Pembrolizumab
Seagen
Antibody-drug conjugate
Astellas Pharma
Transitional cell carcinoma
Bladder cancer
Pfizer
Chemotherapy
Enfortumab vedotin

Click the tags to see associated articles and topics

View Article Details
FDA Fast Tracks 9MW2821 for Esophageal Squamous Cell Carcinoma - Targeted Oncology

Added to Collection on: 2024-02-28 15:22:36

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugate
Biotechnology
Immunology
Nectin
Esophageal cancer
Transitional cell carcinoma
Squamous-cell carcinoma
Pembrolizumab
Nivolumab

Click the tags to see associated articles and topics

View Article Details
Bladder Cancer Pipeline Outlook Report 2024 | CG Oncology, - openPR.com

Added to Collection on: 2024-03-19 15:15:25

Tags for this article:

Seagen
Bladder cancer
G1 Therapeutics
BCG vaccine
Pembrolizumab
Sotio
Merck & Co.
Roche
Transitional cell carcinoma
Ferring Pharmaceuticals
Dermatitis
Astellas Pharma
DelveInsight Business Research LLP

Click the tags to see associated articles and topics

View Article Details
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma

Added to Collection on: 2024-03-21 16:33:32

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Cancer treatments
Carcinoma
Nivolumab
Pembrolizumab
PD-1 and PD-L1 inhibitors
Transitional cell carcinoma
Bladder cancer
Programmed cell death protein 1
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
Yale Urology Research [Q1: January-March 2024]

Added to Collection on: 2024-04-24 17:32:02

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Carcinoma
Transitional cell carcinoma
Pembrolizumab
Nivolumab
Checkpoint inhibitor
Renal cell carcinoma
Avelumab
Cora Sternberg
Draft:Alba Kihn Alarcón

Click the tags to see associated articles and topics

View Article Details